TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards July 13, 1990
TCL Archive Cancer Deaths Level Off For First Time, Klausner Tells House Appropriators. February 18, 2000
TCL Archive Review Group Report: NCI Role In Drug Development Seen As Information Provider November 6, 1998